Epidemiology of lung cancer: A-mini review

Authors

  • Hani Abu Tziam

DOI:

https://doi.org/10.5281/zenodo.7936807

Keywords:

Epidemiology, Cancer, Lung

Abstract

 

Lung cancer remains the leading cause of cancer-related deaths globally, with a distribution pattern dictated by economic development levels. This paper explores the diverse trends in lung cancer incidence and mortality across the world, with a specific focus on the United States, the United Kingdom, Europe, and the BRICS nations (Brazil, Russia, India, China, and South Africa). The rise and subsequent fall of lung cancer cases in developed nations like the U.S. and U.K. are linked to the prevalence of smoking, effective tobacco control programs, and the availability of healthcare services. However, developing countries continue to grapple with high smoking rates, environmental pollutants, and healthcare disparities, leading to a higher burden of death from lung cancer. The examination of racial and ethnic differences in the U.S. and regional differences in Europe further underscore the complex interplay of socio-cultural factors in lung cancer trends. In Asia, particularly in India and China, rising tobacco use has led to a surge in lung cancer cases. In South Africa, occupational hazards like asbestos exposure compound the issue. The need for robust tobacco control policies and accessible healthcare is crucial in mitigating the global lung cancer burden, particularly in low- and middle-income countries where the disease burden is highest.

References

Bade BC, Dela Cruz CS. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020;41(1):1-24.

Oliver AL. Lung Cancer: Epidemiology and Screening. Surg Clin North Am. 2022;102(3):335-44

Schabath MB, Cote ML. Cancer Progress and Priorities: Lung Cancer. Cancer Epidemiol Biomarkers Prev. 2019;28(10):1563-79.

Mao Y, Yang D, He J, Krasna MJ. Epidemiology of Lung Cancer. Surg Oncol Clin N Am. 2016;25(3):439-45.

Schwartz AG, Cote ML. Epidemiology of Lung Cancer. Adv Exp Med Biol. 2016;893:21-41.

Fois SS, Paliogiannis P, Zinellu A, Fois AG, Cossu A, Palmieri G. Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer. Int J Mol Sci. 2021;22(2):612.

Deshpand R, Chandra M, Rauthan A. Evolving trends in lung cancer: Epidemiology, diagnosis, and management. Indian J Cancer. 2022;59(Supplement):S90-S105.

Nasim F, Sabath BF, Eapen GA. Lung Cancer. Med Clin North Am. 2019;103(3):463-73.

Hoy H, Lynch T, Beck M. Surgical Treatment of Lung Cancer. Crit Care Nurs Clin North Am. 2019;31(3):303-313.

Jones GS, Baldwin DR. Recent advances in the management of lung cancer. Clin Med (Lond). 2018;18(Suppl 2):s41-s46.

Torre LA, Siegel RL, Jemal A. Lung Cancer Statistics. Adv Exp Med Biol. 2016;893:1-19.

Lee E, Kazerooni EA. Lung Cancer Screening. Semin Respir Crit Care Med. 2022;43(6):839-50.

Downloads

Published

2023-04-30

How to Cite

1.
Abu Tziam H. Epidemiology of lung cancer: A-mini review. Unicos Rev [Internet]. 2023 Apr. 30 [cited 2024 Mar. 28];2(1):16-8. Available from: https://unicosreview.com/index.php/review/article/view/9